Nano, Encarnacion T.

HRN: 28-60-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/22/2026
03/01/2026
IV
300
Q6
Breast Mass
Remove - Pending Acceptance
02/23/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/23/2026
03/02/2026
IV
2.25
Q8
Sepsis
Checking Initial Appropriateness 
03/01/2026
AZITHROMYCIN 500MG TABLET (TAB)
03/01/2026
03/08/2026
PO
500mg
OD
CAP HR
Checking Initial Appropriateness 
03/04/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/04/2026
03/08/2026
IV
2.25g
Q8
RF Secondary To CAP HR
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: